Invention Grant
- Patent Title: Artificially synthesized peptide H-473 and use thereof
-
Application No.: US17049907Application Date: 2019-01-16
-
Publication No.: US11352392B2Publication Date: 2022-06-07
- Inventor: Yiling Hou , Wanru Hou , Xiang Ding
- Applicant: CHINA WEST NORMAL UNIVERSITY
- Applicant Address: CN Nangchong
- Assignee: CHINA WEST NORMAL UNIVERSITY
- Current Assignee: CHINA WEST NORMAL UNIVERSITY
- Current Assignee Address: CN Nangchong
- Priority: CN201811612034.0 20181227
- International Application: PCT/CN2019/072013 WO 20190116
- International Announcement: WO2020/133605 WO 20200702
- Main IPC: C07K7/06
- IPC: C07K7/06 ; A61K38/00

Abstract:
The invention discloses an artificially synthesized peptide H-473 and use thereof. The peptide H-473 has an amino acid sequence of RGLRGLR, a molecular weight of 827 Da and a PI of 12.30. The invention further discloses use of the peptide H-473 in anti-cancer, anti-senile dementia, analgesia and the like. The peptide H-473 provides scientific basis and direction for research and development of anti-cancer, anti-asthma, anti-senile dementia and analgesia, provides a valuable resource for studying mechanisms of anti-cancer, anti-asthma, anti-senile dementia, analgesia and anti-psoriasis, and provides a new direction for researching novel means for anti-cancer, anti-asthma, anti-senile dementia, analgesia, anti-psoriasis and anti-age-related macular degeneration (AMD).
Public/Granted literature
- US20210230223A1 ARTIFICIALLY SYNTHESIZED PEPTIDE H-473 AND USE THEREOF Public/Granted day:2021-07-29
Information query